Cines; Douglas B.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Cines; Douglas B..The latest application filed is for "fully humanized anti-platelet factor 4 antibodies that treat heparin-induced thrombocytopenia".

Company Profile

3.6.17

Cines; Douglas B. - Wynnewood PA
CINES; Douglas B. - Wyneewood PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Atomic description of immune complex that causes heparin-induced thrombocytopenia Grant 11,435,362 - Greene , et al. September 6, 2	2022-09-06
Fully Humanized Anti-platelet Factor 4 Antibodies That Treat Heparin-induced Thrombocytopenia App 20200165333 - GREENE; Mark I. ; et al.	2020-05-28
Atomic Description Of Immune Complex That Causes Heparin-Induced Thrombocytopenia App 20200003786 - Greene; Mark I. ; et al.	2020-01-02
Atomic description of immune complex that causes heparin-induced thrombocytopenia Grant 10,371,705 - Greene , et al.	2019-08-06
Atomic Description Of Immune Complex That Causes Heparin-induced Thrombocytopenia App 20180024140 - GREENE; Mark I. ; et al.	2018-01-25
Methods And Kits For Diagnosing Heparin-induced Thrombocytopenia App 20150132778 - Cines; Douglas B. ; et al.	2015-05-14
Methods Of Identifying Hit-antibodies And Pf4 Antagonists And Cell Lines For Use Therein App 20150037821 - Watson; Steven P. ; et al.	2015-02-05
Fusion Proteins For Inhibition And Dissolution Of Coagulation Of Thrombi App 20130058929 - MUZYKANTOV; VLADIMIR R. ; et al.	2013-03-07
Targeting recombinant therapeutics to circulating red blood cells Grant 8,333,973 - Muzykantov , et al. December 18, 2	2012-12-18
Compositions Containing Thrombomodulin Domains And Uses Thereof App 20110262466 - Muzykantov; Vladimir R. ; et al.	2011-10-27
Delivery vehicle for recombinant proteins Grant 7,939,063 - Cines , et al. May 10, 2	2011-05-10
Targeting Recombinant Therapeutics To Circulating Red Blood Cells App 20100285015 - Muzykantov; Vladimir R. ; et al.	2010-11-11
Crystal Structure Of Human Urokinase Plasminogen Activator Amino Teminal Fragment Bound To Its Receptor App 20090264628 - Huang; Mingdong ; et al.	2009-10-22
Fusion Proteins For Inhibition And Dissolution Of Coagulation App 20090130104 - Muzykantov; Vladimir R. ; et al.	2009-05-21
Peptide-Mediated Protein Transduction Into Cells of the Hematopoietic Lineage App 20080317761 - Cines; Douglas B. ; et al.	2008-12-25
Compositions and methods for modulating muscle cell and tissue contractility Grant 7,425,534 - Cines , et al. September 16, 2	2008-09-16
Platelet surface PF4 antigenic complexes as a diagnostic indicator in heparin-induced thrombocytopenia App 20070190582 - Poncz; Mortimer ; et al.	2007-08-16
Delivery vehicle for recombinant proteins App 20070031392 - Cines; Douglas B. ; et al.	2007-02-08
Compositions and methods for modulating muscle cell and tissue contractility App 20050158300 - Cines, Douglas B. ; et al.	2005-07-21
Compositions and methods for modulating muscle cell and tissue contractility Grant 6,833,357 - Cines , et al. December 21, 2	2004-12-21
Delivery vehicle for recombinant proteins App 20040126885 - Cines, Douglas B. ; et al.	2004-07-01
Compositions and methods for modulating muscle cell and tissue contractility App 20020131964 - Cines, Douglas B. ; et al.	2002-09-19

Company Registrations

NCAGE Code	46XP4	CINES, DOUGLAS B
CAGE Code	46XP4	CINES, DOUGLAS B
S.A.M. Registration	46XP4 [603921136]	CINES, DOUGLAS B

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.